Aethlon medical appoints medical device and biomedical executive, nicolas gikakis, to its board of directors

San diego , july 6, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced the appointment of nicolas gikakis to its board of directors (board), effective july 3, 2023. mr. gikakis will also serve as a member of the nominating and corporate governance committee of the board.
AEMD Ratings Summary
AEMD Quant Ranking